Century Therapeutics will present preclinical data on iPSC-derived therapies for autoimmune diseases and cancer at the ASGCT meeting. Quiver AI Summary ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate ...

The over 500-line human iPSC repository also continues to grow at JAX, ... The humanized portfolio will add two PBMC humanized models, HuPBMC NCG-B2m-KO and HuPBMC NCG-MHC-dKO, ...

iXCells Biotechnologies focuses on creating a broad portfolio of iPSC-derived off-the-shelf and custom cell models from healthy and patient donors to make “clinical-trials-in-a-plate" a reality ...